SODIUM CHLORIDE EUROS*0.9% 500ML

Sodium Chloride Eurospital 0.9% Solution for Infusion

What it is and what it is used for
Fluid and sodium chloride replacement

What you need to know before taking the medicine
Hypernatremia
Saline overhydration.

Warnings and precautions
Sodium salts should be administered with caution in patients with hypertension, heart failure, peripheral or pulmonary edema, reduced renal function, pre-eclampsia, or other conditions associated with sodium retention (see interactions).
Solutions with a concentration greater than 0.9% (hypertonic solutions) should be used with caution, at a controlled infusion rate, and only when specifically prescribed.
Use with great caution in patients with congestive heart failure, severe renal failure, and in clinical conditions involving edema with salt retention; in patients treated with corticosteroid or corticotropin drugs. Continuous administration without potassium supplementation can cause hypokalemia.
Use with caution in children.
During the infusion, it is good practice to monitor fluid balance, electrolytes, plasma osmolarity, and acid-base balance.

The solution must be clear, colorless, and free of visible particles. Use immediately after opening the container. The container is for single, uninterrupted administration only, and any residue cannot be used.

Possible side effects
Like all medicines, Sodium Chloride can cause side effects, although not everybody gets them.
The side effects of sodium chloride are listed below. There is insufficient data to determine the frequency of the individual effects listed.

Disorders of water and electrolyte balance
Hypernatremia, hypervolemia, plasma hypoosmolarity (for 0.45% solutions), hyperchloremia (which can cause bicarbonate loss leading to acidosis).

Nervous system disorders
Headache, dizziness, restlessness, fever, irritability, weakness, muscle stiffness, convulsions, coma, death

Psychiatric disorders
Drowsiness, confused states

Respiratory, thoracic and mediastinal disorders
Dyspnea, respiratory arrest.

Gastrointestinal disorders
Thirst, reduced salivation, nausea, vomiting, diarrhea, abdominal pain.

Cardiac disorders
Tachycardia.

Eye disorders
Reduced lacrimation.

Kidney and urinary disorders
Renal failure.

Vascular disorders
Hypotension, hypertension, pulmonary and peripheral edema.

Systemic disorders and administration site conditions

Infection at the infusion site, local pain or reaction, venous irritation, venous thrombosis or phlebitis extending from the infusion site, extravasation.

Following the instructions in the package leaflet reduces the risk of side effects.
If any of the side effects worsen, or if you notice any side effect not listed in this package leaflet, inform your doctor or pharmacist.